| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 6.65e-14 | 38 | 137 | 10 | GO:0000146 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 OBSCN RYR2 MYH14 ASPM MYO15A ATP2B1 | 6.59e-10 | 230 | 137 | 14 | GO:0005516 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.62e-09 | 118 | 137 | 10 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 FSCN3 CAPG MYH14 MYO15A | 5.55e-08 | 227 | 137 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8B3 MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 MSH4 HELB MYH14 HELZ2 MYO15A ATP2B1 SNRNP200 | 4.97e-06 | 614 | 137 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 FSCN3 CAPG MYH14 SCNN1A MYO15A | 2.65e-05 | 479 | 137 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | MARS2 PUS3 NEIL1 FTSJ1 MSH4 HELB POLR3F GGT5 HELZ2 PAN3 SNRNP200 QRSL1 TRDMT1 DNTT | 1.43e-04 | 645 | 137 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity | 2.78e-04 | 4 | 137 | 2 | GO:0050510 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 4.80e-04 | 144 | 137 | 6 | GO:0140101 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | MARS2 PUS3 FTSJ1 POLR3F GGT5 HELZ2 PAN3 SNRNP200 QRSL1 TRDMT1 | 6.16e-04 | 417 | 137 | 10 | GO:0140098 |
| GeneOntologyMolecularFunction | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 6.88e-04 | 6 | 137 | 2 | GO:0047238 | |
| GeneOntologyBiologicalProcess | muscle contraction | ARHGAP42 DOCK4 MYH1 MYH2 MYH4 MYH8 MYH11 MYH13 RYR2 MYH14 SCN9A PDE5A SMPD3 ATP2B1 UTY | 5.33e-08 | 400 | 134 | 15 | GO:0006936 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 7.12e-07 | 153 | 134 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle system process | ARHGAP42 DOCK4 MYH1 MYH2 MYH4 MYH8 MYH11 MYH13 RYR2 MYH14 SCN9A PDE5A SMPD3 ATP2B1 UTY | 2.80e-06 | 547 | 134 | 15 | GO:0003012 |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle contraction | 4.68e-05 | 31 | 134 | 4 | GO:0014829 | |
| GeneOntologyBiologicalProcess | regulation of vascular associated smooth muscle contraction | 5.65e-05 | 12 | 134 | 3 | GO:0003056 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 WASHC4 FSCN3 CAPG OBSCN ITGB5 RYR2 MYH14 TBCK SCN9A MYO15A UTY | 8.88e-05 | 912 | 134 | 17 | GO:0030029 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 1.15e-04 | 15 | 134 | 3 | GO:0030049 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular associated smooth muscle contraction | 1.25e-04 | 3 | 134 | 2 | GO:1904694 | |
| GeneOntologyBiologicalProcess | actin filament bundle distribution | 1.25e-04 | 3 | 134 | 2 | GO:0070650 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.60e-04 | 124 | 134 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.83e-04 | 127 | 134 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 2.04e-04 | 18 | 134 | 3 | GO:0033275 | |
| GeneOntologyCellularComponent | myosin filament | 3.15e-16 | 25 | 137 | 10 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.06e-13 | 28 | 137 | 9 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 5.01e-12 | 59 | 137 | 10 | GO:0016459 | |
| GeneOntologyCellularComponent | muscle myosin complex | 5.39e-10 | 16 | 137 | 6 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin II filament | 2.75e-07 | 3 | 137 | 3 | GO:0097513 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 FSCN3 CAPG APBB3 MYH14 SCNN1A MYO15A | 2.63e-05 | 576 | 137 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | A band | 3.75e-04 | 52 | 137 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.65e-04 | 290 | 137 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 6.81e-04 | 223 | 137 | 7 | GO:0098862 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | ATP8B3 ATG9B TMEM59 CHSY1 COG8 COG1 CHSY3 SMPD3 DENND5A CLBA1 | 6.91e-04 | 443 | 137 | 10 | GO:0098791 |
| GeneOntologyCellularComponent | actomyosin contractile ring | 8.76e-04 | 7 | 137 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | perichromatin fibrils | 1.16e-03 | 8 | 137 | 2 | GO:0005726 | |
| GeneOntologyCellularComponent | integrin complex | 1.19e-03 | 32 | 137 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.35e-03 | 73 | 137 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.45e-03 | 254 | 137 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | Golgi transport complex | 1.85e-03 | 10 | 137 | 2 | GO:0017119 | |
| GeneOntologyCellularComponent | mitotic spindle | 2.13e-03 | 201 | 137 | 6 | GO:0072686 | |
| GeneOntologyCellularComponent | myofibril | 2.18e-03 | 273 | 137 | 7 | GO:0030016 | |
| Domain | Myosin-like_IQ_dom | 2.62e-17 | 19 | 136 | 10 | IPR027401 | |
| Domain | - | 2.62e-17 | 19 | 136 | 10 | 4.10.270.10 | |
| Domain | IQ | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 OBSCN LRRIQ1 MYH14 SCN9A ASPM MYO15A | 1.01e-16 | 71 | 136 | 14 | PF00612 |
| Domain | Myosin_N | 2.12e-16 | 15 | 136 | 9 | PF02736 | |
| Domain | Myosin_N | 2.12e-16 | 15 | 136 | 9 | IPR004009 | |
| Domain | IQ | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 OBSCN LRRIQ1 MYH14 SCN9A ASPM MYO15A | 7.17e-16 | 81 | 136 | 14 | SM00015 |
| Domain | Myosin_tail_1 | 2.02e-15 | 18 | 136 | 9 | PF01576 | |
| Domain | Myosin_tail | 2.02e-15 | 18 | 136 | 9 | IPR002928 | |
| Domain | IQ_motif_EF-hand-BS | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 OBSCN LRRIQ1 MYH14 SCN9A ASPM MYO15A | 3.36e-15 | 90 | 136 | 14 | IPR000048 |
| Domain | IQ | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 OBSCN LRRIQ1 MYH14 SCN9A ASPM MYO15A | 5.42e-15 | 93 | 136 | 14 | PS50096 |
| Domain | Myosin_head_motor_dom | 1.19e-13 | 38 | 136 | 10 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.19e-13 | 38 | 136 | 10 | PS51456 | |
| Domain | Myosin_head | 1.19e-13 | 38 | 136 | 10 | PF00063 | |
| Domain | MYSc | 1.19e-13 | 38 | 136 | 10 | SM00242 | |
| Domain | VWFA | 3.31e-04 | 82 | 136 | 5 | PS50234 | |
| Domain | VWA | 3.70e-04 | 84 | 136 | 5 | SM00327 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 MSH4 HELB LRRIQ1 MYH14 HELZ2 ASPM MYO15A SNRNP200 | 4.53e-04 | 848 | 136 | 16 | IPR027417 |
| Domain | Myosin_S1_N | 5.19e-04 | 5 | 136 | 2 | IPR008989 | |
| Domain | Integrin_dom | 7.72e-04 | 25 | 136 | 3 | IPR032695 | |
| Domain | Integrin_b_cyt | 7.75e-04 | 6 | 136 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 7.75e-04 | 6 | 136 | 2 | PF08725 | |
| Domain | Integrin_bsu_cyt_dom | 7.75e-04 | 6 | 136 | 2 | IPR014836 | |
| Domain | VWF_A | 7.86e-04 | 99 | 136 | 5 | IPR002035 | |
| Domain | Integrin_B_tail | 1.08e-03 | 7 | 136 | 2 | SM01242 | |
| Domain | Integrin_bsu_tail | 1.08e-03 | 7 | 136 | 2 | IPR012896 | |
| Domain | GAF | 1.08e-03 | 7 | 136 | 2 | PF01590 | |
| Domain | Integrin_B_tail | 1.08e-03 | 7 | 136 | 2 | PF07965 | |
| Domain | VWA_3 | 1.43e-03 | 8 | 136 | 2 | PF13768 | |
| Domain | Chond_GalNAc | 1.43e-03 | 8 | 136 | 2 | IPR008428 | |
| Domain | GAF | 1.43e-03 | 8 | 136 | 2 | IPR003018 | |
| Domain | INB | 1.43e-03 | 8 | 136 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 1.43e-03 | 8 | 136 | 2 | IPR002369 | |
| Domain | CHGN | 1.43e-03 | 8 | 136 | 2 | PF05679 | |
| Domain | Integrin_beta | 1.43e-03 | 8 | 136 | 2 | PF00362 | |
| Domain | GAF | 1.43e-03 | 8 | 136 | 2 | SM00065 | |
| Domain | Integrin_bsu | 1.83e-03 | 9 | 136 | 2 | IPR015812 | |
| Domain | - | 1.83e-03 | 9 | 136 | 2 | 3.30.450.40 | |
| Domain | INTEGRIN_BETA | 1.83e-03 | 9 | 136 | 2 | PS00243 | |
| Domain | PSI_integrin | 1.83e-03 | 9 | 136 | 2 | PF17205 | |
| Domain | Integin_beta_N | 1.83e-03 | 9 | 136 | 2 | IPR033760 | |
| Domain | GAF_dom-like | 1.83e-03 | 9 | 136 | 2 | IPR029016 | |
| Domain | - | 2.09e-03 | 74 | 136 | 4 | 3.40.50.410 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.42e-09 | 70 | 106 | 9 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 6.42e-07 | 132 | 106 | 9 | M11355 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.07e-05 | 19 | 106 | 4 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.07e-05 | 19 | 106 | 4 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.33e-05 | 20 | 106 | 4 | M18415 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.64e-05 | 21 | 106 | 4 | M27494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 2.40e-05 | 23 | 106 | 4 | MM15222 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.86e-05 | 24 | 106 | 4 | M2243 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 6.21e-05 | 29 | 106 | 4 | M27309 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 5.67e-12 | 6 | 139 | 5 | 10077619 | |
| Pubmed | 1.98e-11 | 7 | 139 | 5 | 35210422 | ||
| Pubmed | 2.44e-10 | 4 | 139 | 4 | 10388558 | ||
| Pubmed | 7.34e-10 | 12 | 139 | 5 | 8424456 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.22e-09 | 5 | 139 | 4 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.22e-09 | 5 | 139 | 4 | 12919077 | |
| Pubmed | 1.22e-09 | 5 | 139 | 4 | 6196357 | ||
| Pubmed | 3.64e-09 | 6 | 139 | 4 | 1728586 | ||
| Pubmed | 3.64e-09 | 6 | 139 | 4 | 30044719 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.64e-09 | 6 | 139 | 4 | 10588881 | |
| Pubmed | 8.47e-09 | 7 | 139 | 4 | 16819597 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 6.25e-08 | 3 | 139 | 3 | 26059207 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 36515178 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 20685736 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 25567808 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 15177565 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 15774463 | ||
| Pubmed | Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. | 6.25e-08 | 3 | 139 | 3 | 14594953 | |
| Pubmed | Characterization of three full-length human nonmuscle myosin II paralogs. | 6.25e-08 | 3 | 139 | 3 | 24072716 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 15845534 | ||
| Pubmed | 7.89e-08 | 11 | 139 | 4 | 8136524 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.70e-07 | 13 | 139 | 4 | 8404542 | |
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 27184118 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 20357587 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 2.49e-07 | 4 | 139 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 2.49e-07 | 4 | 139 | 3 | 18417546 | |
| Pubmed | Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. | 2.49e-07 | 4 | 139 | 3 | 18697221 | |
| Pubmed | Nonmuscle myosins IIA and IIB are present in adult motor nerve terminals. | 2.49e-07 | 4 | 139 | 3 | 16012337 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 11023856 | ||
| Pubmed | Effect of Mts1 on the structure and activity of nonmuscle myosin II. | 2.49e-07 | 4 | 139 | 3 | 9405067 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 16895968 | ||
| Pubmed | Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. | 6.21e-07 | 5 | 139 | 3 | 19439495 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 33871354 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 6.21e-07 | 5 | 139 | 3 | 30737693 | |
| Pubmed | Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. | 6.21e-07 | 5 | 139 | 3 | 25006807 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 6.21e-07 | 5 | 139 | 3 | 11121372 | |
| Pubmed | Nonmuscle myosin II regulation of lung epithelial morphology. | 1.24e-06 | 6 | 139 | 3 | 22972683 | |
| Pubmed | 1.24e-06 | 6 | 139 | 3 | 15034141 | ||
| Pubmed | 1.24e-06 | 6 | 139 | 3 | 20417199 | ||
| Pubmed | 1.24e-06 | 6 | 139 | 3 | 15292239 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 1.24e-06 | 6 | 139 | 3 | 17559643 | |
| Pubmed | 1.69e-06 | 22 | 139 | 4 | 24301466 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 2.16e-06 | 7 | 139 | 3 | 29758057 | |
| Pubmed | Nonmuscle myosin II isoform and domain specificity during early mouse development. | 2.16e-06 | 7 | 139 | 3 | 20679233 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 EIF3E TARDBP TGM2 MYH14 ATP2B1 | 2.17e-06 | 647 | 139 | 13 | 26618866 |
| Pubmed | Convergence and extrusion are required for normal fusion of the mammalian secondary palate. | 3.45e-06 | 8 | 139 | 3 | 25848986 | |
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 33667029 | ||
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 3.45e-06 | 8 | 139 | 3 | 17429076 | |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 3.45e-06 | 8 | 139 | 3 | 14667415 | |
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 26993635 | ||
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 3864153 | ||
| Pubmed | beta-Catenin is a Nek2 substrate involved in centrosome separation. | 3.45e-06 | 8 | 139 | 3 | 18086858 | |
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 33424621 | ||
| Pubmed | 5.16e-06 | 9 | 139 | 3 | 31960486 | ||
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 19506036 | ||
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 7.34e-06 | 10 | 139 | 3 | 24825879 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 7.34e-06 | 10 | 139 | 3 | 8950513 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 9.14e-06 | 33 | 139 | 4 | 32094117 | |
| Pubmed | 1.01e-05 | 11 | 139 | 3 | 18310078 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.01e-05 | 11 | 139 | 3 | 16024798 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.01e-05 | 11 | 139 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 1.01e-05 | 11 | 139 | 3 | 29168801 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21792479 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15013951 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22328520 | ||
| Pubmed | Nonmuscle myosin II-B is required for normal development of the mouse heart. | 1.59e-05 | 2 | 139 | 2 | 9356462 | |
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 1.59e-05 | 2 | 139 | 2 | 9585413 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19109430 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8873145 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17020881 | ||
| Pubmed | The distinct roles of myosin IIA and IIB under compression stress in nucleus pulposus cells. | 1.59e-05 | 2 | 139 | 2 | 33415745 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16575183 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18946352 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33188738 | ||
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 1.59e-05 | 2 | 139 | 2 | 9382868 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11150240 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 1.59e-05 | 2 | 139 | 2 | 22337492 | |
| Pubmed | The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor. | 1.59e-05 | 2 | 139 | 2 | 18096694 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29486156 | ||
| Pubmed | Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. | 1.59e-05 | 2 | 139 | 2 | 10906735 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8089273 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22025714 | ||
| Pubmed | Chondroitin sulfate synthase-3. Molecular cloning and characterization. | 1.59e-05 | 2 | 139 | 2 | 12907687 | |
| Pubmed | Myosin-IIA and ICAM-1 regulate the interchange between two distinct modes of T cell migration. | 1.59e-05 | 2 | 139 | 2 | 19201857 | |
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 1.59e-05 | 2 | 139 | 2 | 11551968 | |
| Pubmed | Expression of four myosin heavy chain isoforms with development in mouse uterus. | 1.59e-05 | 2 | 139 | 2 | 8402956 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27737892 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 7916668 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21106542 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11029059 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16596254 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16316347 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25185263 | ||
| Pubmed | Non-Muscle Myosin II Isoforms Have Different Functions in Matrix Rearrangement by MDA-MB-231 Cells. | 1.59e-05 | 2 | 139 | 2 | 26136073 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15258581 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22191382 | ||
| Pubmed | Myosin II isoforms play distinct roles in adherens junction biogenesis. | 1.59e-05 | 2 | 139 | 2 | 31486768 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17215127 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9725909 | ||
| Interaction | RSPH6A interactions | 7.79e-08 | 34 | 131 | 6 | int:RSPH6A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 9.47e-05 | 346 | 139 | 7 | chr17p13 | |
| GeneFamily | Myosin heavy chains | 9.14e-18 | 15 | 94 | 9 | 1098 | |
| GeneFamily | Olfactory receptors, family 11 | 2.24e-04 | 23 | 94 | 3 | 159 | |
| GeneFamily | Components of oligomeric golgi complex | 7.34e-04 | 8 | 94 | 2 | 493 | |
| GeneFamily | CD molecules|Integrin beta subunits | 9.40e-04 | 9 | 94 | 2 | 1159 | |
| GeneFamily | Actins|Deafness associated genes | 2.86e-03 | 113 | 94 | 4 | 1152 | |
| GeneFamily | Beta 4-glycosyltransferases | 3.46e-03 | 17 | 94 | 2 | 425 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 3.24e-06 | 20 | 137 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 3.99e-06 | 21 | 137 | 4 | MM1102 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN | 1.04e-05 | 199 | 137 | 8 | M2921 | |
| Coexpression | HALLMARK_MYOGENESIS | 1.08e-05 | 200 | 137 | 8 | M5909 | |
| Coexpression | GHANDHI_BYSTANDER_IRRADIATION_DN | 2.97e-05 | 12 | 137 | 3 | M2599 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.14e-07 | 152 | 139 | 7 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 1.43e-06 | 177 | 139 | 7 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.92e-06 | 185 | 139 | 7 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.23e-06 | 135 | 139 | 6 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.38e-06 | 145 | 139 | 6 | a9f5a32abcf3eb2c66bd65f2521a6dd4ce56c635 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.69e-06 | 156 | 139 | 6 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-05 | 159 | 139 | 6 | e9c51e611ebd427bbe51e3e036c14122c36ea372 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-05 | 161 | 139 | 6 | f5da03c426f3124ea302bd343b6bca81cafee858 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-05 | 162 | 139 | 6 | 4e3bf16799c6552366d4c7e42b1328a05dcad7e7 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.80e-05 | 174 | 139 | 6 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-05 | 175 | 139 | 6 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 177 | 139 | 6 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 177 | 139 | 6 | b5c20c1247f11ebc97e9cb47482564cd74e36ca6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.18e-05 | 180 | 139 | 6 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-05 | 181 | 139 | 6 | 6a32eb83aa39484ca43c91e6b58302d8dea84b7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 182 | 139 | 6 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 182 | 139 | 6 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 2.39e-05 | 183 | 139 | 6 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 110 | 139 | 5 | 5496c92932195386025254b9129d69b12c8e3340 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 110 | 139 | 5 | 41306a2d4a5a39569437eb123e47f98ef8afab24 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 110 | 139 | 5 | 1fe08060248b25329f73b80d74435c108bee1359 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 186 | 139 | 6 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 186 | 139 | 6 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nefm_(Layer_6a)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.63e-05 | 55 | 139 | 4 | b0d37faccc8d04433ee0e76cbce2410530c4c8a1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nefm_(Layer_6a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.63e-05 | 55 | 139 | 4 | c3ebea1420b68638ed465a8cd8efba860650b795 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.70e-05 | 187 | 139 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 189 | 139 | 6 | 1b84ff069e95ff113d8d861f38e07a08eb3d7070 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 189 | 139 | 6 | f4b8415edf538ce152703ad2c07be96af12b1acd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.95e-05 | 190 | 139 | 6 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.04e-05 | 191 | 139 | 6 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.04e-05 | 191 | 139 | 6 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-05 | 193 | 139 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-05 | 193 | 139 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-05 | 194 | 139 | 6 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-05 | 194 | 139 | 6 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 194 | 139 | 6 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 3.42e-05 | 195 | 139 | 6 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 3.42e-05 | 195 | 139 | 6 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 3.42e-05 | 195 | 139 | 6 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-05 | 196 | 139 | 6 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-05 | 196 | 139 | 6 | a44a648bf209ce037bfc7b3adfcb220aab60728c | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-05 | 196 | 139 | 6 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-05 | 196 | 139 | 6 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.62e-05 | 197 | 139 | 6 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | Transverse-T_cell-Tfh|Transverse / Region, Cell class and subclass | 3.83e-05 | 199 | 139 | 6 | cbef8f95edf2e86e16c448a76068d7ed8f6b7748 | |
| ToppCell | Transverse-(1)_T_cell-(16)_Tfh|Transverse / shred on region, Cell_type, and subtype | 3.83e-05 | 199 | 139 | 6 | aa31e26d48066f865ca33251a33a28934c0a7a44 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.83e-05 | 199 | 139 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 199 | 139 | 6 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 199 | 139 | 6 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 200 | 139 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 200 | 139 | 6 | 641c875ab1403e02d5d47a6f645d27273c2ee056 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | e5a8647c47a49c8c90c78d681193946de103d8ff | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.93e-05 | 200 | 139 | 6 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.23e-05 | 62 | 139 | 4 | 9db88da996b9977f5a89afe505cd55e7b5324bc9 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.23e-05 | 62 | 139 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.23e-05 | 62 | 139 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.23e-05 | 62 | 139 | 4 | 461d280a1b955033186cfc326f9ace85b4a53c54 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-05 | 131 | 139 | 5 | cc5b5afab8622e98f673fa116a226d930c295327 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.05e-05 | 137 | 139 | 5 | 885e4cfc237eca1fa2eb1f2fd8d84f151e21ecfa | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.22e-05 | 145 | 139 | 5 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-05 | 145 | 139 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.91e-05 | 77 | 139 | 4 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-04 | 149 | 139 | 5 | 4fda987bc7bb6d1dbd41b8f1f8c1bc59613255a8 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 154 | 139 | 5 | a39877cdf7b441b5c953f744ed30f1d5acf4ea19 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 155 | 139 | 5 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 155 | 139 | 5 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 82 | 139 | 4 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 82 | 139 | 4 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 82 | 139 | 4 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 156 | 139 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 157 | 139 | 5 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-04 | 157 | 139 | 5 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 158 | 139 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 158 | 139 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 159 | 139 | 5 | a5509f0604ef0caef5ed1af83dd89c86686c73cc | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-04 | 160 | 139 | 5 | 8308ca6f37986c526432a0fbc5f7ec2e75cfb6d7 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.46e-04 | 160 | 139 | 5 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 139 | 5 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 160 | 139 | 5 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 161 | 139 | 5 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 161 | 139 | 5 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 161 | 139 | 5 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 163 | 139 | 5 | 8569abb769543be55e066119c1dd1c505d5a177e | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 165 | 139 | 5 | 6708beb0e8094f30cf5cd812e6a67a6db004a580 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.69e-04 | 165 | 139 | 5 | d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 165 | 139 | 5 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 165 | 139 | 5 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 165 | 139 | 5 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-04 | 165 | 139 | 5 | d91fabc5b26c27577eea27be8a305fec5c004164 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 165 | 139 | 5 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | Immune_cells|World / Lineage and Cell class | 1.74e-04 | 166 | 139 | 5 | f20b58528749ee88fba3ccdaf3f3fa0d06cb9a91 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 166 | 139 | 5 | 05d3e7f441089d788a192d7fa1ec5c302d1ca202 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-04 | 167 | 139 | 5 | 49d9220f22d10ff06c0512c9c40c26ad51728e4f | |
| Drug | formycin triphosphate | 4.29e-13 | 51 | 136 | 10 | CID000122274 | |
| Drug | purealin | 1.69e-12 | 58 | 136 | 10 | CID006419303 | |
| Drug | clenbuterol | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 SCN9A SCNN1A MYO15A | 5.67e-11 | 142 | 136 | 12 | CID000002783 |
| Drug | blebbistatin | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 RGMA MYH14 MYO15A | 1.06e-10 | 116 | 136 | 11 | CID003476986 |
| Drug | S-(-)-Etomoxir | 4.54e-10 | 100 | 136 | 10 | CID000060765 | |
| Drug | NSC107658 | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 CAPG ITGAM SLC2A10 MYH14 MYO15A TUBD1 PKN3 | 4.80e-10 | 306 | 136 | 15 | CID000002919 |
| Drug | B0683 | 2.15e-09 | 117 | 136 | 10 | CID006398969 | |
| Drug | MgCl2 | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 PUS3 STON1 MYH13 CAPG MYH14 MYO15A TUBD1 ATP2B1 | 3.52e-09 | 354 | 136 | 15 | CID000024584 |
| Drug | NSC339663 | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 GAB2 SLC2A10 MYH14 MYO15A TUBD1 | 3.61e-09 | 250 | 136 | 13 | CID000003892 |
| Drug | nifedipine | CACNA1E MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 RYR2 GGT5 CACNA2D4 NR1I2 MYH14 ATP2B1 PKN3 | 3.96e-09 | 415 | 136 | 16 | CID000004485 |
| Drug | fast white | 5.26e-09 | 42 | 136 | 7 | CID000024008 | |
| Drug | verapamil | CACNA1E MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 RYR2 CACNA2D4 NR1I2 MYH14 SCN9A SCNN1A ATP2B1 PKN3 | 6.06e-09 | 490 | 136 | 17 | CID000002520 |
| Drug | candesartan cilexetil | 1.72e-08 | 145 | 136 | 10 | CID000002540 | |
| Drug | oxovanadium | 4.43e-08 | 120 | 136 | 9 | CID000024411 | |
| Drug | trifluoperazine | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 GAB2 MYH14 MYO15A ATP2B1 PKN3 | 7.78e-08 | 324 | 136 | 13 | CID000005566 |
| Drug | isoproterenol | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 ITGAM RYR2 CACNA2D4 MYH14 SCN9A SCNN1A PDE5A MYO15A TUBD1 PKN3 | 1.02e-07 | 669 | 136 | 18 | CID000003779 |
| Drug | AC1NRBPQ | 1.39e-07 | 137 | 136 | 9 | CID005288569 | |
| Drug | D-triiodothyronine | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 GGT5 SLC2A10 CD3G MYH14 NCOA1 ATP2B1 | 1.70e-07 | 409 | 136 | 14 | CID000000861 |
| Drug | AC1L1IZ2 | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 RYR2 MYH14 MYO15A TUBD1 | 3.00e-07 | 304 | 136 | 12 | CID000004795 |
| Drug | eye gene | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 CACNA2D4 MYH14 PDE5A MYO15A PKN3 | 3.46e-07 | 369 | 136 | 13 | CID000004782 |
| Drug | carvedilol | 5.49e-07 | 161 | 136 | 9 | CID000002585 | |
| Drug | SM-2 | 9.12e-07 | 87 | 136 | 7 | CID000486033 | |
| Drug | AC1LADJ6 | 1.16e-06 | 130 | 136 | 8 | CID000486032 | |
| Drug | K-Cl | CACNA1E MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 CAPG RYR2 CACNA2D4 MYH14 MYO15A ATP2B1 | 1.58e-06 | 567 | 136 | 15 | CID000004873 |
| Drug | LY294002 | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 GRB10 ITGAM GAB2 SLC2A10 PARP10 MYH14 SCNN1A PKN3 DNTT | 2.43e-06 | 748 | 136 | 17 | CID000003973 |
| Drug | AC1N9ZZC | 3.23e-06 | 149 | 136 | 8 | CID004369374 | |
| Drug | 4-chloroaniline | 3.61e-06 | 202 | 136 | 9 | CID000007812 | |
| Drug | NSC226080 | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 EIF3E ACVR2A LILRB1 RYR2 TGM2 NUAK1 MYH14 QRSL1 PKN3 | 4.39e-06 | 782 | 136 | 17 | CID000005040 |
| Drug | nocodazole | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 COG1 MYH14 STRC ESPL1 TUBD1 | 5.93e-06 | 477 | 136 | 13 | CID000004122 |
| Drug | 2bq7 | 9.28e-06 | 123 | 136 | 7 | CID006540267 | |
| Drug | Isoxazoles | 1.14e-05 | 8 | 136 | 3 | ctd:D007555 | |
| Drug | G 3012 | 1.47e-05 | 132 | 136 | 7 | CID000120739 | |
| Drug | creatine | 2.15e-05 | 193 | 136 | 8 | CID000000586 | |
| Drug | isradipine | 3.06e-05 | 100 | 136 | 6 | CID000003784 | |
| Drug | procaine | 3.81e-05 | 153 | 136 | 7 | CID000004914 | |
| Drug | pyrophosphate | MARS2 MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 STON1 MYH13 CD3G MYH14 MYO15A DNTT | 3.83e-05 | 654 | 136 | 14 | CID000001023 |
| Drug | NSC611747 | 5.21e-05 | 352 | 136 | 10 | CID000002534 | |
| Drug | carbachol | CACNA1E MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 RYR2 CACNA2D4 MYH14 ATP2B1 PKN3 | 6.61e-05 | 688 | 136 | 14 | CID000002551 |
| Drug | wartmannin | MYH1 MYH2 MYH4 MYH8 MYH9 MYH10 MYH11 MYH13 GRB10 ITGAM GAB2 SLC2A10 MYH14 MYO15A PKN3 | 1.05e-04 | 811 | 136 | 15 | CID000005691 |
| Drug | bepridil | 1.11e-04 | 126 | 136 | 6 | CID000002351 | |
| Drug | Fura-2AM | 1.12e-04 | 79 | 136 | 5 | CID000105091 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 3.66e-10 | 10 | 129 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 3.66e-10 | 10 | 129 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 3.66e-10 | 10 | 129 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 3.66e-10 | 10 | 129 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 3.66e-10 | 10 | 129 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 3.66e-10 | 10 | 129 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 3.66e-10 | 10 | 129 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 3.66e-10 | 10 | 129 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.14e-09 | 12 | 129 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.14e-09 | 12 | 129 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.85e-09 | 13 | 129 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 4.28e-09 | 15 | 129 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 7.05e-07 | 71 | 129 | 6 | DOID:0050700 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.18e-06 | 48 | 129 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.29e-05 | 33 | 129 | 4 | DOID:10003 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.73e-05 | 80 | 129 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | post-operative stroke, response to surgery | 1.88e-04 | 5 | 129 | 2 | EFO_0009951, EFO_0009956 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 1.88e-04 | 5 | 129 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Nonsyndromic genetic hearing loss | 3.51e-04 | 76 | 129 | 4 | cv:C5680182 | |
| Disease | Hereditary hearing loss and deafness | 4.66e-04 | 146 | 129 | 5 | cv:C0236038 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 8.34e-04 | 10 | 129 | 2 | DOID:7693 (is_marker_for) | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.43e-03 | 13 | 129 | 2 | C3501611 | |
| Disease | response to tenofovir, creatinine clearance measurement | 1.50e-03 | 112 | 129 | 4 | EFO_0007934, EFO_0009279 | |
| Disease | femoral neck bone mineral density | 1.74e-03 | 196 | 129 | 5 | EFO_0007785 | |
| Disease | systemic lupus erythematosus, COVID-19 | 2.11e-03 | 58 | 129 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | FEV/FEC ratio | ARHGAP42 USP34 MYH9 EIF3E GAB2 ME3 EFHC1 TBCK SYT4 DENND5A MYO15A ATP2B1 CNTN2 | 2.86e-03 | 1228 | 129 | 13 | EFO_0004713 |
| Disease | vital capacity | EPHB3 USP34 MYH2 STON1 TRIM24 RYR2 SLC2A10 LRRIQ1 NCOA1 CHSY3 VWA5B1 ARHGEF6 PDE11A | 3.02e-03 | 1236 | 129 | 13 | EFO_0004312 |
| Disease | anti-Mullerian hormone measurement | 3.42e-03 | 20 | 129 | 2 | EFO_0004769 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.59e-03 | 447 | 129 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | stroke | 3.74e-03 | 144 | 129 | 4 | EFO_0000712 | |
| Disease | Metabolic Syndrome X | 3.77e-03 | 21 | 129 | 2 | C0524620 | |
| Disease | Bronchiectasis | 4.14e-03 | 22 | 129 | 2 | C0006267 | |
| Disease | type 1 diabetes mellitus | 4.30e-03 | 242 | 129 | 5 | MONDO_0005147 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIFNLERLFDLANGC | 3066 | Q96N23 | |
| NCIELNAATISGFLF | 106 | P09693 | |
| LGNFEEVCTFQQTLC | 286 | Q15052 | |
| IRGNQVTFQDCFIAD | 196 | Q5SY80 | |
| NCFTVNRSLFIFGED | 61 | Q15878 | |
| ILGRSETQECLFFNA | 21 | P27037 | |
| QNSDFVLGQFCFLQR | 966 | O60423 | |
| LQFDFFETEGNDVCK | 631 | P13497 | |
| FDFAVTNLAVDLQCG | 961 | Q8IZT6 | |
| ERNVFEGIFNNAIFC | 996 | P20020 | |
| LFLFNNSLSELQGEC | 226 | Q86UN2 | |
| LVLNCLNFDFIGSSA | 221 | Q9H2T7 | |
| VCEANANVGFLAFDQ | 271 | Q8IXN7 | |
| ANVGFLAFDQACNLD | 276 | Q8IXN7 | |
| ATFLLEELGFQLFCN | 91 | D6REC4 | |
| QIQIEGDFLQCSFSI | 306 | Q8WTU0 | |
| QSCVVEFILLGFSNF | 6 | P58181 | |
| FAFVNEFILQGFSCE | 21 | Q8NH07 | |
| SLFQLAFLVNLAFCG | 156 | O95013 | |
| FVAVNSGFICLLNFL | 196 | Q96R67 | |
| SIEENFLQFLQGTGC | 376 | Q9BZJ8 | |
| LVCLLEDNGFATQQA | 171 | Q96AQ8 | |
| DFIFPTQSLLFENCQ | 1401 | Q5T1H1 | |
| ICEALLDQRFFNGIG | 161 | Q96FI4 | |
| ALQIDSFGLVTCFQQ | 716 | Q9NVR5 | |
| EQFPCAFEFNENFLL | 411 | Q96EF0 | |
| GFEDLSFNSFEQLCI | 1591 | Q9UKN7 | |
| LQLDFGLSCLEQEFL | 36 | O95528 | |
| SFGLFSCIINGEEQE | 476 | Q9UQF2 | |
| DAGFLGDALQLFLQC | 291 | Q17RB8 | |
| DLLLCVGNFFGSTQD | 36 | Q69YN2 | |
| QLAFCDFLFLFVGLN | 116 | Q8N140 | |
| GFEIFQLNSFEQLCI | 481 | Q7Z406 | |
| AGFEIFDFNSLEQLC | 466 | P13535 | |
| DFSAQDCLTALGQVF | 316 | A0A0J9YX94 | |
| FLLGNLSFVDICQAS | 61 | Q8NGD3 | |
| AGFEIFDFNSLEQLC | 466 | Q9UKX2 | |
| LFEAFVIFCGLGINN | 546 | Q9HCR9 | |
| ERQFFSEVCSLGQQE | 436 | Q32NB8 | |
| RNDEQFLEAFVIFCG | 486 | O76074 | |
| FLEAFVIFCGLGIQN | 491 | O76074 | |
| ACFLNNILVAFNDLR | 436 | Q96MW5 | |
| NCALDSFLRLNDGQF | 716 | P54753 | |
| LNETQFSAFRGQECI | 81 | Q96KN4 | |
| AGFEIFDFNSLEQLC | 466 | P12882 | |
| FEIFDLNSFEQLCIN | 456 | P35579 | |
| FELCQLRFNTVFNAE | 281 | O75469 | |
| FFIQDQIALVERGGC | 81 | Q9BSG0 | |
| VFEGFLDSNELCQFI | 331 | Q9H579 | |
| AFFPANLDFLCLQEV | 351 | Q9NY59 | |
| LVAFDVVCGDFNFDN | 501 | Q9NY59 | |
| DVARECFNIGNFNSL | 291 | Q0VAM2 | |
| EDLNLFFTATCQDGV | 391 | P18084 | |
| AGFLALCQSQIREFN | 1161 | Q96JM4 | |
| GFDAILQAALCQEQI | 261 | P26010 | |
| CDFGFAQNITPAELQ | 6606 | Q5VST9 | |
| CFENTFQELIAAANG | 871 | Q58A45 | |
| LIADLGRQSFQCAAF | 376 | O95704 | |
| FAQGCQIVDLADLTQ | 411 | Q14674 | |
| LQQVLFLLESCTEFG | 1051 | Q14674 | |
| CLAIVNNFVFLLGGE | 321 | Q96M94 | |
| QTLLFERVFVNLDGC | 161 | Q9BXI9 | |
| FQFQDVTGEFVACLL | 906 | Q8N1I0 | |
| QSFLFSLCQEINRVG | 746 | Q8WTW3 | |
| QFIGRAFCDQQLLTV | 476 | Q9H0R6 | |
| SDLDCFVIDNNGFIL | 886 | Q7Z3S7 | |
| FALNFCIELQGSNLL | 451 | Q9NQT6 | |
| QFLQATAQEEGIFEC | 726 | Q6NUI2 | |
| CLELQENSDLEFGFQ | 571 | Q6P9A2 | |
| EQALACGLFEEQQAF | 1696 | Q3T8J9 | |
| FFLNVVQAVSQEGAC | 556 | P36269 | |
| ALVGQQVTLECFAFG | 251 | Q02246 | |
| NDFFLVACLEDFIEN | 321 | P60228 | |
| ELLGVENVFQLFTCA | 291 | Q6IQ26 | |
| ENVFQLFTCALLEFQ | 296 | Q6IQ26 | |
| NGFACILLEDVFQLG | 206 | Q674R7 | |
| FGINCLIQFEDFANA | 271 | Q16798 | |
| CDQFTQVFLESQGIE | 186 | Q5JVL4 | |
| NFQILPCEDDGQTFF | 541 | Q13322 | |
| NTGDCFILDLGQNIF | 161 | P40121 | |
| QFNRLVAEFLVGSEC | 1531 | Q9BYK8 | |
| QASCLVLFFLVGFAQ | 6 | P59796 | |
| EEDTLGNFIFACRFN | 271 | P37088 | |
| QDDEFTCDLFRFLQL | 3831 | Q92736 | |
| FESNVRLCNGEIFFI | 826 | Q8NG08 | |
| AGFEIFELNSFEQLC | 461 | P35580 | |
| FAFVNEFILQGFSCE | 21 | Q8NG94 | |
| FAFVNEFILQGFTCE | 21 | B2RN74 | |
| LEAQFQCVFGTERLA | 536 | Q53GL7 | |
| CGVAFLRLEDFLDNA | 381 | Q6P5Z2 | |
| SLFQLAFLVNLAFCG | 156 | Q6IEY1 | |
| INLNFCEQVDAGLTF | 61 | Q9UQC2 | |
| NAVFNELFVFDIPCE | 351 | Q9H2B2 | |
| DFFCQLGHFNLLLED | 91 | O14607 | |
| TIENCGFQYQEFLLS | 136 | O14717 | |
| PFQLCQFEVTGQAFL | 261 | Q9BZE2 | |
| CGNIVTFAQFLFIAV | 31 | Q969S0 | |
| VEFLIDNCFEIFGEN | 266 | Q8N103 | |
| FVTFADDQIAQSLCG | 231 | Q13148 | |
| LNNCNQIFTDAFDIL | 161 | P04053 | |
| VILQCDSQVAFDGFS | 141 | Q8NHL6 | |
| SQSLQDFQFECIGDA | 61 | A6NI28 | |
| IQLIFNNFLECGVSD | 586 | Q5UIP0 | |
| NNFLECGVSDERFFL | 591 | Q5UIP0 | |
| LLEALDGFFFVVNCE | 116 | Q15788 | |
| GCIFDLVTNQAFDIS | 1506 | Q15858 | |
| AGFEIFDFNSLEQLC | 466 | Q9Y623 | |
| CVQELLQDEELFFGL | 371 | O15457 | |
| CVSAENFLQIQDFEG | 601 | O60285 | |
| DFESEFVEVLNQQCF | 171 | Q9H1D9 | |
| QCDIPFFGIQEEFNA | 1031 | P11215 | |
| LAGADFLFLCFQIIN | 71 | Q96LB1 | |
| QACVFDLLTTGDVNF | 376 | Q96B86 | |
| QLQGFCLGETFATEL | 1351 | Q7RTU9 | |
| FAFGVDTELNCFVLQ | 246 | Q86WD7 | |
| FNGTDFIDCLEIFLN | 231 | P53597 | |
| FAFLGFLGCLVNLQA | 141 | Q9UBY8 | |
| FNNESLLFFCDVDLV | 621 | Q86X52 | |
| AQFDNDTLLLFCDVD | 706 | Q70JA7 | |
| SRCQENFFLVLGIDA | 216 | Q96F83 | |
| DFQCALLANLFASEG | 151 | Q9H0W9 | |
| AGFEIFEVNSFEQLC | 461 | P35749 | |
| NFGQFEDGILDICLI | 181 | P21980 | |
| CGNQIGFEVFDALLS | 11 | Q9UJT1 | |
| LFSICQFVDDGIDLN | 76 | Q9BXS4 | |
| VADFRLIFQNCAEFN | 966 | O15164 | |
| CFVNGNLECFLTLND | 446 | Q9Y6Q2 | |
| DQLQNCFTLLAESLF | 256 | Q14765 | |
| EFETDCRIFLNLVNG | 256 | Q9BX26 | |
| TFIGNNAAIQELFTC | 366 | A6NNZ2 | |
| GFEIFDFNSLEQLCI | 466 | Q9UKX3 | |
| GNFLIADECFQAAVA | 136 | Q8IYF3 | |
| CLSIQDFRGDFQNTF | 321 | Q68DE3 | |
| CFELFGFDILIDDNL | 366 | Q9BWV7 | |
| FQQLFQEAGISCTDF | 121 | Q96GW9 | |
| LANGFNECILLFSDL | 671 | Q8TEA7 | |
| ECENQLVLLLGFNTF | 301 | O75643 | |
| FQLFQGVTRAVDLCA | 36 | Q9UET6 | |
| EDLTNRCNVFIQGFL | 431 | Q2M389 | |
| LQQLNAQREFGFLCD | 11 | Q8N680 | |
| LQGQCLFEQCAFLDA | 141 | Q8NEE8 | |
| LFEQCAFLDALNVFS | 146 | Q8NEE8 | |
| FLLSTENEGNLHFQC | 96 | P0CG31 | |
| GETIGNELFNCRQFI | 731 | Q70CQ2 | |
| FGEELFDFNQCEKAL | 86 | Q9BR84 | |
| QLASGAFLLNEAFCE | 1056 | Q5TIE3 | |
| LVNPFCQETLFVGND | 556 | Q6UXF1 |